首頁 > 市場調查報告書 > 醫療設備

生技設備

市場調查報告書

商品編碼

1800278

全球微流體市場：2025-2030年預測

Global Microfluidics Market - Forecasts fom 2025 to 2030

出版日期: 2025年08月15日 | 出版商:

Knowledge Sourcing Intelligence | 英文 140 Pages | 商品交期: 最快1-2個工作天內

價格

簡介目錄

微流體市場預計將從 2025 年的 336.9 億美元成長到 2030 年的 476.9 億美元，複合年成長率為 7.20%。

預計微流體市場將在2025年至2030年間強勁成長，這得益於照護現場（POC）需求的不斷成長、實驗室晶片技術的進步以及醫療保健領域對高性能篩檢日益成長的需求。微流體能夠精確操作微小樣本，對於開發用於癌症檢測和傳染病檢查等應用的可攜式高效診斷設備至關重要。技術創新和不斷上漲的醫療成本（尤其是在美國）推動市場的發展。挑戰包括高昂的開發成本和監管障礙。

市場促進因素

對照護現場(POC) 設備的需求不斷成長

即時診斷（POC）的日益普及，尤其是在醫療保健領域，是微流體市場的主要驅動力。這些設備利用微流體技術，能夠快速、可攜式檢測新冠病毒（SARS-CoV-2）、血糖濃度和心臟標記等疾病，從而提高可及性和效率。例如，尿液試紙和肌鈣蛋白檢測等POC檢測的廣泛應用依賴於微流體平台進行精確的小體積樣本分析。由於微流體支援小型化和經濟實惠，診所和家庭對分散式檢查的需求正在推動市場發展。

診斷技術的進步

微流體（例如實驗室晶片系統）的創新，透過實現快速精準的診斷，正在推動市場成長。 2023年7月，賽默飛世爾科技推出了Diomni企業軟體，以簡化分子檢測並提高實驗室效率。這些進步提高了診斷的準確性和適應性，支持癌症檢測等應用，而微流體在這些應用中可以實現早期分析和個人化治療。美國癌症發生率的上升凸顯了對此類技術的需求，進一步推動了市場擴張。

醫療支出增加

醫療保健支出的不斷成長，尤其是在美國，正在推動微流體在高階診斷領域的應用。美國醫療保健產業正在大力投資創新解決方案，從而增加了對基於微流體技術的即時檢測 (POC) 設備的需求，這些設備可以改善患者治療效果並降低成本。對慢性病精準診斷的關注以及微流體在高性能篩檢中的整合是推動該地區市場成長的關鍵因素。

市場限制

微流體市場面臨挑戰，因為高昂的開發和製造成本可能會限制其在成本敏感地區和應用領域的應用。複雜的監管環境，包括嚴格的醫療設備核准標準，構成了市場准入的障礙。此外，設計和操作微流體系統所需的專業知識可能會阻礙其在新興市場的成長。透過經濟高效的生產和精簡的監管流程來應對這些挑戰，對於持續擴張至關重要。

The global microfluidics market is projected to experience robust growth from 2025 to 2030, driven by the increasing demand for point-of-care (POC) diagnostics, advancements in lab-on-a-chip technologies, and the rising need for high-throughput screening in healthcare. Microfluidics, enabling precise manipulation of low-volume samples, is critical for developing portable, efficient diagnostic devices used in applications like cancer detection and infectious disease testing. The market is propelled by technological innovations and growing healthcare expenditures, particularly in the United States. Challenges include high development costs and regulatory hurdles.

Market Drivers

Rising Demand for Point-of-Care (POC) Devices

The increasing adoption of POC diagnostics, particularly in healthcare, is a primary driver of the microfluidics market. These devices, leveraging microfluidic technology, enable rapid, portable testing for conditions like SARS-CoV-2, glucose levels, and cardiac markers, enhancing accessibility and efficiency. For instance, widespread use of POC tests, such as urine dipstick and troponin assays, relies on microfluidic platforms for accurate, low-volume sample analysis. The demand for decentralized testing in clinics and home settings is boosting the market, as microfluidics supports miniaturization and affordability.

Advancements in Diagnostic Technologies

Innovations in microfluidics, such as lab-on-a-chip systems, are driving market growth by enabling rapid and precise diagnostics. In July 2023, Thermo Fisher Scientific launched Diomni Enterprise Software, streamlining molecular testing and enhancing lab efficiency. Such advancements improve diagnostic accuracy and adaptability, supporting applications like cancer detection, where microfluidics enables early-stage analysis and personalized treatment. The rising incidence of cancer in the United States underscores the need for these technologies, further fueling market expansion.

Growing Healthcare Expenditure

Increasing healthcare spending, particularly in the United States, is supporting the adoption of microfluidics in advanced diagnostics. The U.S. healthcare industry's substantial investment in innovative solutions drives demand for microfluidic-based POC devices that improve patient outcomes and reduce costs. The focus on precision diagnostics for chronic diseases and the integration of microfluidics in high-throughput screening are key factors enhancing market growth in this region.

Market Restraints

The microfluidics market faces challenges due to high development and manufacturing costs, which can limit adoption in cost-sensitive regions or applications. Regulatory complexities, including stringent standards for medical device approval, pose barriers to market entry. Additionally, the need for specialized expertise to design and operate microfluidic systems may hinder growth in emerging markets. Addressing these challenges through cost-effective production and streamlined regulatory processes will be critical for sustained expansion.

Market Segmentation

By Application

The market is segmented into POC diagnostics, in vitro diagnostics (IVD), high-throughput screening, and others. POC diagnostics dominate due to their widespread use in healthcare for rapid testing. IVD and high-throughput screening are growing segments, driven by demand for precision diagnostics and drug development.

By Technology

The market includes lab-on-a-chip, microfluidic cartridges, and others. Lab-on-a-chip leads due to its versatility in diagnostics, while microfluidic cartridges are critical for POC applications.

By Geography

The market is segmented into North America, Asia-Pacific, Europe, South America, and the Middle East and Africa. North America, led by the United States, holds a significant share due to its large healthcare market and focus on advanced diagnostics. Asia-Pacific is expected to grow rapidly, driven by increasing healthcare investments and industrialization in countries like China and India. Europe, South America, and the Middle East and Africa are emerging markets with growing potential.

The microfluidics market is set for robust growth from 2025 to 2030, driven by demand for POC diagnostics, advancements in lab-on-a-chip technologies, and rising healthcare expenditures. Innovations like Thermo Fisher's Diomni Enterprise Software, launched in July 2023, highlight the market's transformative potential. Despite challenges like high costs and regulatory hurdles, the outlook is positive, particularly in North America and Asia-Pacific. Industry players must focus on cost-effective, scalable solutions to capitalize on the growing demand for microfluidics in precision diagnostics and healthcare applications.

Key Benefits of this Report:

Insightful Analysis: Gain detailed market insights covering major as well as emerging geographical regions, focusing on customer segments, government policies and socio-economic factors, consumer preferences, industry verticals, and other sub-segments.
Competitive Landscape: Understand the strategic maneuvers employed by key players globally to understand possible market penetration with the correct strategy.
Market Drivers & Future Trends: Explore the dynamic factors and pivotal market trends and how they will shape future market developments.
Actionable Recommendations: Utilize the insights to exercise strategic decisions to uncover new business streams and revenues in a dynamic environment.
Caters to a Wide Audience: Beneficial and cost-effective for startups, research institutions, consultants, SMEs, and large enterprises.

What do businesses use our reports for?

Industry and Market Insights, Opportunity Assessment, Product Demand Forecasting, Market Entry Strategy, Geographical Expansion, Capital Investment Decisions, Regulatory Framework & Implications, New Product Development, Competitive Intelligence

Report Coverage:

Historical data from 2020 to 2024 & forecast data from 2025 to 2030
Growth Opportunities, Challenges, Supply Chain Outlook, Regulatory Framework, and Trend Analysis
Competitive Positioning, Strategies, and Market Share Analysis
Revenue Growth and Forecast Assessment of segments and regions including countries
Company Profiling (Strategies, Products, Financial Information, and Key Developments among others.

Segmentation:

By Component

Chips
Pumps
Sensors
Others

By Sector

Industrial
Healthcare

By Application

Point-of-care (POC) Diagnostics
Drug Delivery Systems
In-Vitro Diagnostics (IVD)
Pharmaceutical and Life Sciences Research

By Geography

North America
USA
Canada
Mexico
South America
Brazil
Argentina
Others
Europe
Germany
France
United Kingdom
Spain
Others
Middle East and Africa
Saudi Arabia
UAE
Others
Asia Pacific
China
Japan
India
South Korea
Indonesia
Thailand
Others

1. EXECUTIVE SUMMARY

2. MARKET SNAPSHOT

2.1. Market Overview
2.2. Market Definition
2.3. Scope of the Study
2.4. Market Segmentation

3. BUSINESS LANDSCAPE

3.1. Market Drivers
3.2. Market Restraints
3.3. Market Opportunities
3.4. Porter's Five Forces Analysis
3.5. Industry Value Chain Analysis
3.6. Policies and Regulations
3.7. Strategic Recommendations

4. TECHNOLOGICAL OUTLOOK

5. GLOBAL MICROFLUIDS MARKET BY COMPONENT

5.1. Introduction
5.2. Chips
5.3. Pumps
5.4. Sensors
5.5. Others

6. GLOBAL MICROFLUIDS MARKET BY SECTOR

6.1. Introduction
6.2. Industrial
6.3. Healthcare

7. GLOBAL MICROFLUIDS MARKET BY APPLICATION

7.1. Introduction
7.2. Point-of-care (POC) Diagnostics
7.3. Drug Delivery Systems
7.4. In-Vitro Diagnostics (IVD)
7.5. Pharmaceutical and Life Sciences Research

8. GLOBAL MICROFLUIDS MARKET BY GEOGRAPHY

8.1. Introduction
8.2. North America
- 8.2.1. USA
- 8.2.2. Canada
- 8.2.3. Mexico
8.3. South America
- 8.3.1. Brazil
- 8.3.2. Argentina
- 8.3.3. Others
8.4. Europe
- 8.4.1. Germany
- 8.4.2. France
- 8.4.3. United Kingdom
- 8.4.4. Spain
- 8.4.5. Others
8.5. Middle East and Africa
- 8.5.1. Saudi Arabia
- 8.5.2. UAE
- 8.5.3. Others
8.6. Asia Pacific
- 8.6.1. China
- 8.6.2. India
- 8.6.3. Japan
- 8.6.4. South Korea
- 8.6.5. Indonesia
- 8.6.6. Thailand
- 8.6.7. Others